UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

Population‐based study of disease trajectory after radical treatment for high‐risk prostate cancer

BJU international, 2024-07, Vol.134 (1), p.96-102

2024

Volltextzugriff (PDF)

Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease

PloS one, 2017-09, Vol.12 (9), p.e0184173-e0184173

2017

Volltextzugriff (PDF)

Outcomes for Patients after Resection of Pulmonary Metastases from Clear Cell Renal Cell Carcinoma: 18 Years of Experience

Urologia internationalis, 2019-10, Vol.103 (3), p.297-302

2019

Volltextzugriff (PDF)

Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial

BJU international, 2024-06

2024

Volltextzugriff (PDF)

Re: Prostate Cancer Polygenic Risk Score and Prediction of Lethal Prostate Cancer

European urology, 2023-05, Vol.83 (5), p.473-474

2023

Volltextzugriff (PDF)

Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial

Asian journal of andrology, 2023-11, Vol.25 (6), p.653-661

2023

Volltextzugriff (PDF)

Urine-Based Biomarker Test Uromonitor ® in the Detection and Disease Monitoring of Non-Muscle-Invasive Bladder Cancer-A Systematic Review and Meta-Analysis of Diagnostic Test Performance

Cancers, 2024-02, Vol.16 (4), p.753

2024

Volltextzugriff (PDF)

Re: Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non–muscle-invasive Bladder Cancer

European urology, 2024-08

2024

Volltextzugriff (PDF)

Does the Identification of a Minimum Number of Cases Correlate With Better Adherence to International Guidelines Regarding the Treatment of Penile Cancer? Survey Results of the European PROspective Penile Cancer Study (E-PROPS)

Frontiers in oncology, 2021-11, Vol.11, p.759362-759362

2021

Volltextzugriff (PDF)

Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561–70

European urology, 2024-02, Vol.85 (2), p.e47-e48

2024

Volltextzugriff (PDF)

Re: Androgen-deprivation Therapies for Prostate Cancer and Risk of Infection by SARS-CoV-2: A Population-based Study (n = 4532)

European urology, 2020-12, Vol.78 (6), p.930-931

2020

Volltextzugriff (PDF)

Apalutamide and Overall Survival in Prostate Cancer

European urology, 2021-01, Vol.79 (1), p.150-158

2021

Volltextzugriff (PDF)

Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology

European urology focus, 2019-11, Vol.5 (6), p.1029-1057

2019

Volltextzugriff (PDF)

Assessment of Patient Risk Profiles by a Male Sexual Health Direct-to-Consumer Prescription Platform: A Cross-Sectional Study

Telemedicine reports, 2023-06, Vol.4 (1), p.118-125

2023

Volltextzugriff (PDF)

The Phase 3 COU-AA-302 Study of Abiraterone Acetate Plus Prednisone in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Stratified Analysis Based on Pain, Prostate-specific Antigen, and Gleason Score

European urology, 2018-07, Vol.74 (1), p.17-23

2018

Volltextzugriff (PDF)

Cystic Appearance on Imaging Methods (Bosniak III-IV) in Histologically Confirmed Papillary Renal Cell Carcinoma is Mainly Characteristic of Papillary Renal Cell Carcinoma Type 1 and Might Predict a Relatively Indolent Behavior of Papillary Renal Cell Carcinoma

Urologia internationalis, 2018-11, Vol.101 (4), p.409-416

2018

Volltextzugriff (PDF)

How does artificial intelligence master urological board examinations? A comparative analysis of different Large Language Models’ accuracy and reliability in the 2022 In-Service Assessment of the European Board of Urology

World journal of urology, 2024-01, Vol.42 (1), p.20-20, Article 20

2024

Volltextzugriff (PDF)

Challenges and Opportunities in Establishing Appropriate Intermediate Endpoints Reflecting Patient Benefit: A Roadmap for Research and Clinical Application in Nonmetastatic Prostate Cancer

European urology, 2024-08, Vol.86 (2), p.81-87

2024

Volltextzugriff (PDF)

Bladder cancer with secondary muscle invasion - a prognostic dilemma

Scandinavian journal of urology, 2022-07, Vol.56 (4), p.334-335

2022

Volltextzugriff (PDF)

A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients

World journal of urology, 2023-12, Vol.41 (12), p.3535-3542

2023

Volltextzugriff (PDF)

Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN study

European journal of cancer (1990), 2023-11, Vol.193, p.113290-113290, Article 113290

2023

Volltextzugriff (PDF)

Re: Differences in Survival Associated with Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database

European urology, 2018-11, Vol.74 (5), p.678-679

2018

Volltextzugriff (PDF)

Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN

British journal of cancer, 2024-01, Vol.130 (1), p.73-81

2024

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(78)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Population‐based study of disease trajectory after radical treatment for high‐risk prostate cancer

Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease

Outcomes for Patients after Resection of Pulmonary Metastases from Clear Cell Renal Cell Carcinoma: 18 Years of Experience

Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial

Time to recurrence is a significant predictor of cancer‐specific survival after recurrence in patients with recurrent renal cell carcinoma – results from a comprehensive multi‐centre database (CORONA/SATURN‐Project)

Re: Prostate Cancer Polygenic Risk Score and Prediction of Lethal Prostate Cancer

Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial

Urine-Based Biomarker Test Uromonitor ® in the Detection and Disease Monitoring of Non-Muscle-Invasive Bladder Cancer-A Systematic Review and Meta-Analysis of Diagnostic Test Performance

Re: Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non–muscle-invasive Bladder Cancer

Does the Identification of a Minimum Number of Cases Correlate With Better Adherence to International Guidelines Regarding the Treatment of Penile Cancer? Survey Results of the European PROspective Penile Cancer Study (E-PROPS)

Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561–70

Re: Androgen-deprivation Therapies for Prostate Cancer and Risk of Infection by SARS-CoV-2: A Population-based Study (n = 4532)

Apalutamide and Overall Survival in Prostate Cancer

Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology

Assessment of Patient Risk Profiles by a Male Sexual Health Direct-to-Consumer Prescription Platform: A Cross-Sectional Study

The Phase 3 COU-AA-302 Study of Abiraterone Acetate Plus Prednisone in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Stratified Analysis Based on Pain, Prostate-specific Antigen, and Gleason Score

Cystic Appearance on Imaging Methods (Bosniak III-IV) in Histologically Confirmed Papillary Renal Cell Carcinoma is Mainly Characteristic of Papillary Renal Cell Carcinoma Type 1 and Might Predict a Relatively Indolent Behavior of Papillary Renal Cell Carcinoma

How does artificial intelligence master urological board examinations? A comparative analysis of different Large Language Models’ accuracy and reliability in the 2022 In-Service Assessment of the European Board of Urology

Challenges and Opportunities in Establishing Appropriate Intermediate Endpoints Reflecting Patient Benefit: A Roadmap for Research and Clinical Application in Nonmetastatic Prostate Cancer

Bladder cancer with secondary muscle invasion - a prognostic dilemma

A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients

Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN study

Re: Differences in Survival Associated with Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database

Prostate-specific Membrane Antigen Positron Emission Tomography–detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective Study

Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN

Suchergebnisse filtern